How patients' families pushed rare-disease therapy to cusp of clinical trial — until biotech's cash halted progress
The gene therapy company had aimed to start a clinical trial by the end of last year but laid off scores of employees, focused its work on two other programs and lost its founding CEO and chief medical officer.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Ron Leuty Source Type: news
More News: Biotechnology | Clinical Trials | Gene Therapy | Genetics | Health Management | Rare Diseases